<SEC-DOCUMENT>0001213900-20-030221.txt : 20201006
<SEC-HEADER>0001213900-20-030221.hdr.sgml : 20201006
<ACCEPTANCE-DATETIME>20201006104246
ACCESSION NUMBER:		0001213900-20-030221
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20200924
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201006
DATE AS OF CHANGE:		20201006

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Silo Pharma, Inc.
		CENTRAL INDEX KEY:			0001514183
		STANDARD INDUSTRIAL CLASSIFICATION:	APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
		IRS NUMBER:				462137136
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54872
		FILM NUMBER:		201225858

	BUSINESS ADDRESS:	
		STREET 1:		1086 TEANECK ROAD
		STREET 2:		SUITE 3A
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666
		BUSINESS PHONE:		(718) 400-9031

	MAIL ADDRESS:	
		STREET 1:		1086 TEANECK ROAD
		STREET 2:		SUITE 3A
		CITY:			TEANECK
		STATE:			NJ
		ZIP:			07666

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Uppercut Brands, Inc.
		DATE OF NAME CHANGE:	20190808

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Point Capital, Inc.
		DATE OF NAME CHANGE:	20130130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gold Swap Inc
		DATE OF NAME CHANGE:	20110301
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea127840-8k_silopharma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of earliest event reported):&nbsp;September
24, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SILO PHARMA, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of registrant in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-54872</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27-3046338</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or jurisdiction of</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation or organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>560 Sylvan Ave, Suite 3160</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Englewood Cliffs NJ 07632</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(718) 400-9031</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&rsquo;s telephone number)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Uppercut Brands Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(See General Instructions A.2 below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px"></TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:&nbsp;<B>None.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in; text-align: left"><B>Item 5.02</B></TD><TD STYLE="text-align: justify"><B>Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Appointment of Directors</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective October 1,
2020, the board of directors (the &ldquo;Board&rdquo;) of Silo Pharma, Inc. (the &ldquo;Company&rdquo;) appointed Dr. Kevin Mu&ntilde;oz
as a director of the Company to fill a vacancy on the Board. The board of directors has determined Dr. Mu&ntilde;oz is independent
in accordance with the applicable rules of the Nasdaq Stock Market LLC. Dr. Mu&ntilde;oz will serve on the Board&rsquo;s Audit
and Compensation Committees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dr. Mu&ntilde;oz was
not selected as a director pursuant to any arrangements or understandings with the Company or with any other person, and there
are no related party transactions between Dr. Mu&ntilde;oz and the Company that would require disclosure under Item 404(a) of Regulation
S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Set forth below is
the biographical information of Dr. Mu&ntilde;oz, as required by Item 401 of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dr. Kevin Mu&ntilde;oz,
42, is currently the Director of Operations at Physical Medicine and Rehabilitation, an outpatient facility for the treatment of
musculoskeletal issues, and has served in various capacities with Physical Medicine and Rehabilitation since 2008. Dr. Mu&ntilde;oz
holds an MD from Xavier University School of Medicine and a BS from the University of Michigan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 5.03</B></TD><TD STYLE="text-align: justify"><B>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Change of Name</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 24, 2020,
the Company <FONT STYLE="background-color: white">filed&nbsp;</FONT>with the Delaware Secretary of State a certificate of amendment
(the &ldquo;Amendment&rdquo;) to the Company&rsquo;s Certificate of Incorporation to change the legal name of the Company from
&ldquo;Uppercut Brands Inc.&rdquo; to &ldquo;Silo Pharma, Inc.&rdquo;&nbsp;<FONT STYLE="background-color: white">A copy of the
Amendment effecting the name change, as filed with the&nbsp;</FONT>Delaware Secretary of State&nbsp;<FONT STYLE="background-color: white">is
attached hereto as Exhibit 3.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 8.01</B></TD><TD><B>Other Events.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September 28, 2020, the Company issued
a press release announcing its name change to Silo Pharma, Inc., a copy of which is filed as Exhibit 99.1.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October 6, 2020, the Company issued a
press release announcing the appointment of Dr. Kevin Mu&ntilde;oz, MD to the Company&rsquo;s Board of Directors, a copy of which
is filed as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.75in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The exhibits listed in the following Exhibit Index are filed
as part of this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; border-bottom: black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit<BR>
        Number</B></P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 90%; border-bottom: black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea127840ex3-1_silopharma.htm" STYLE="-sec-extract: exhibit">Certificate of Amendment filed with the Delaware Secretary of State on September 24, 2020</A></FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea127840ex99-1_silopharma.htm" STYLE="-sec-extract: exhibit">Press Release dated September 28, 2020</A></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ea127840ex99-2_silopharma.htm">Press Release dated October 6, 2020</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SILO PHARMA, INC.</B></FONT></TD></TR>
<TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October 6, 2020</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Eric Weisblum</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Eric Weisblum,</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea127840ex3-1_silopharma.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT FILED WITH THE DELAWARE SECRETARY OF STATE ON SEPTEMBER 24, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B><IMG SRC="image_001.jpg" ALT="">&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea127840ex99-1_silopharma.htm
<DESCRIPTION>PRESS RELEASE DATED SEPTEMBER 28, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">Uppercut Brands, Inc. Changes Name to Silo Pharma, Inc.;
reflecting Company&rsquo;s Emerging Focusing on the Development and Commercialization of Psychedelic/Psilocybin-based Drug Therapies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><B><I>Early Entrant, Addressing Massive
Market Opportunity for Psychedelic Drug Therapies<BR>
 for a Wide-Range of Conditions, Including PTSD and Parkinson&rsquo;s Disease;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><B><I>Company to Trade Under New Symbol
SILO</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><B>NEW YORK , Sept. 28, 2020 (GLOBE NEWSWIRE) --&nbsp;</B>Uppercuts
Brands, Inc. (OTC Pink: UCUT) today announced that it has completed its name change to Silo Pharma, Inc. (&ldquo;Silo&rdquo; or
&ldquo;the Company&rdquo;) and will trade under the stock ticker symbol SILO effective today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">&ldquo;This name change is a significant step in our transformation
to a biopharmaceutical company focused on the development and commercialization of disruptive psychedelic drug therapies,&rdquo;
commented Eric Weisblum, Silo Pharma&rsquo;s Chief Executive Officer. &ldquo;As one of the first US publicly-traded entrants into
the emerging psilocybin-based drug market, we are pursuing opportunities to sponsor clinical research and subsequently license
drug therapies for the treatment of major emotional disturbances such as PTSD, depression, anxiety and addiction as well as other
neurological disorders such as Alzheimer&rsquo;s and Parkinson&rsquo;s.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">Weisblum continued, &ldquo;Now more than ever, creative
new therapies are needed to address the growing mental health challenges that are being further exacerbated by turbulent economic
conditions and the recent global health crisis. &nbsp;Early lab studies with psychedelic drugs, like psilocybin, have shown promising
indications producing neurological responses that could potentially treat a wide variety of emotional and neurological disorders.
We are pursuing multiple opportunities to partner with leading medical universities to license and/or develop assets based upon
psychedelic drug therapies that could be transformative to the health and well-being of patients. Our business is well-capitalized,
and we believe that combining our resources with leading medical researchers will lead to significant advances in the psychedelic
category.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">&ldquo;The FDA has recently granted &lsquo;Breakthrough
Therapy Designations&rsquo; for a number of psychedelic based therapies, accelerating the clinical process, and with decriminalization
just beginning, we believe that we are well-positioned at the forefront of an enormous and emerging opportunity,&rdquo; added Weisblum.
&ldquo;In the coming weeks and months, we will be updating investors with additions to our scientific advisory board, sponsored
research/licensing deals with universities and an uplisting to the OTCQB Market.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><B>About Silo Pharma</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">Silo Pharma is an early stage biopharmaceutical company
focused on the use of psychedelic proprietary therapeutics for patients suffering from indications such as depression, PTSD, Alzheimer&rsquo;s
and other rare neurological disorders.&nbsp; For more information, visit&nbsp;<FONT STYLE="color: blue">www.silopharma.com</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><B>Safe Harbor and Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">This news release contains &quot;forward-looking statements&quot;
within the meaning of the &ldquo;safe-harbor&rdquo; provisions of the Private Securities Litigation Reform Act of 1995. These statements
are identified by the use of words &ldquo;could&rdquo;, &ldquo;believe&rdquo;, &ldquo;anticipate&rdquo;, &ldquo;intend&rdquo;,
&ldquo;estimate&rdquo;, &ldquo;expect&rdquo;, &ldquo;may&rdquo;, &ldquo;continue&rdquo;, &ldquo;predict&rdquo;, &ldquo;potential&rdquo;
and similar expressions that are intended to identify forward-looking statements. Such statements involve known and unknown risks,
uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (&ldquo;Silo&rdquo; or &ldquo;the Company&rdquo;)
to differ materially from the results expressed or implied by such statements, including changes to anticipated sources of revenues,
future economic and competitive conditions, difficulties in developing the Company&rsquo;s technology platforms, retaining and
expanding the Company&rsquo;s customer base, fluctuations in consumer spending on the Company&rsquo;s products and other factors.
Accordingly, although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there
can be no assurance that such expectations will prove to be correct. The Company disclaims any obligations to publicly update or
release any revisions to the forward-looking information contained in this presentation, whether as a result of new information,
future events or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as
required by law.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Company Contact</U>:</B></FONT></TD>
    <TD STYLE="width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Investor Relations Contact</U>:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SiloPharma, Inc.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hayden IR</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Weisblum, CEO</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brett Maas</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">718-498-9890</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">646-536-7331</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;<FONT STYLE="color: blue">eric@silopharma.com</FONT></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:&nbsp;<FONT STYLE="color: blue">brett@haydenir.com</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>
<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ea127840ex99-2_silopharma.htm
<DESCRIPTION>PRESS RELEASE DATED OCTOBER 6, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Silo Pharma, Inc. Expands Board with
Appointment of Dr. Kevin Mu&ntilde;oz MD;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Announces Application to Uplist to OTCQB
Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEW YORK &ndash; October 6, 2020 &ndash;
</B>Silo Pharma, Inc. (OTC Pink: SILO), which recently announced its transformation to a developmental stage biopharmaceutical
company focused on the use of psilocybin as a therapeutic, today announced the appointment of Dr. Kevin Mu&ntilde;oz, MD, to its
Board of Directors effective October 1, 2020. In addition, the Company filed an application with the OTC Markets Group, Inc. on
September 22, 2020 to uplist from the OTC Pink Open Market to the OTCQB Venture Market tier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Dr. Munoz has a strong working knowledge
of healthcare operations with more than 15 years in the field including clinical research,&rdquo; said Eric Weisblum, CEO of Silo
Pharma. &ldquo;Through his professional experiences, he has demonstrated a proven ability to collaborate and improve operational
processes to elevate the quality of patient care. We look forward to leveraging his expertise and broad experience to further our
mission. Kevin&rsquo;s experience with &ldquo;big data&rdquo; will also help us target the proper indications and patient population
that would benefit from psilocybin-based therapeutics.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Mu&ntilde;oz currently serves as Director
of Operations at Physical Medicine and Rehabilitation where he has responsibility for the day-to-day management of all office operations
with a focus on ensuring and increasing patient satisfaction. Prior to that, he led the configuration efforts during an enterprise-wide
implementation of application software that also included streamlining and improving business processes. Kevin began his career
with Harlem Health Promotion Center in New York City as a Research Assistant where he was responsible for data collection and interpretation.
Dr. Mu&ntilde;oz earned a Bachelor of Science from the University of Michigan where he graduated with distinction and a Doctor
of Medicine from Xavier University School of Medicine, Aruba NA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Moving to a higher OTC Market tier
will provide us with greater visibility within the investment community and with stakeholders as we pursue new opportunities for
investment in psychedelic drug research including psilocybin,&rdquo; added Weisblum. &ldquo;A listing on OTCQB significantly broadens
the universe of potential investors in the Company. Historically, companies that have made the move up to the OTCQB tier have experienced
an increase in liquidity and access to investment capital.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to move expeditiously
to secure the listing on the OTCQB Venture Market tier, which remains subject to OTC Market approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Silo Pharma </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Silo Pharma is an early stage biopharmaceutical
company that has recently began to focus on the development and use of assets and therapies involving the use of drugs, such as
psilocybin or LSD, for patients suffering from indications such as depression, PTSD, Parkinson&rsquo;s and other rare neurological
disorders. For more information, visit www.silopharma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Safe Harbor and Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This news release contains &quot;forward-looking
statements&quot; within the meaning of the &ldquo;safe-harbor&rdquo; provisions of the Private Securities Litigation Reform Act
of 1995. These statements are identified by the use of words &ldquo;could&rdquo;, &ldquo;believe&rdquo;, &ldquo;anticipate&rdquo;,
&ldquo;intend&rdquo;, &ldquo;estimate&rdquo;, &ldquo;expect&rdquo;, &ldquo;may&rdquo;, &ldquo;continue&rdquo;, &ldquo;predict&rdquo;,
&ldquo;potential&rdquo; and similar expressions that are intended to identify forward-looking statements. Such statements involve
known and unknown risks, uncertainties and other factors that could cause the actual results of Silo Pharma, Inc. (&ldquo;Silo&rdquo;
or &ldquo;the Company&rdquo;) to differ materially from the results expressed or implied by such statements, including changes
to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company&rsquo;s
technology platforms, retaining and expanding the Company&rsquo;s customer base, fluctuations in consumer spending on the Company&rsquo;s
products and other factors. Accordingly, although the Company believes that the expectations reflected in such forward-looking
statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company disclaims any
obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether
as a result of new information, future events or otherwise, after the date of this presentation or to reflect the occurrence of
unanticipated events except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; padding-right: -9pt; font-weight: bold; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Company Contact</U>:</FONT></TD>
    <TD STYLE="width: 47%; padding-right: -9pt; font-weight: bold; text-align: justify"><FONT STYLE="font-size: 10pt"><U>Investor Relations Contact</U>:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">Silo Pharma, Inc.</FONT></TD>
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">Hayden IR</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Weisblum, CEO</FONT></TD>
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brett Maas</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">718-498-9890</FONT></TD>
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">646-536-7331 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">Email: eric@silopharma.com</FONT></TD>
    <TD STYLE="padding-right: -9.35pt"><FONT STYLE="font-size: 10pt">Email: brett@haydenir.com </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !V 1,# 2(  A$! Q$!_\0
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MNWY;=#IJ<SI;K?6WX?J6J***](Y0HHHH **** "BBB@ HHHH **** "BBB@
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M;'S1<0$+.!@^CCT/^-.M;I+N'>H9&!P\;?>1NX-3UC.FI:2.B,[:H9%()5R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -V JT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #6
M[4VG-VIM(:"H+YG6PN&C<HXC8JP RIP<'GC\ZGILD:31-%*BO&X*LK#(8'J"
M*'L,\UT'QQJ<&FV9OQ)JLUU:64Z%55&$DL$LCI\BXX$.1D#[XR0.1)X?\;ZH
M^H065Y$MW]HF$"3O((PKXD8 A8^X0_\ ?/O71W,GA;2YDT=].A0H8[E+:'3F
M=%.X(C@(A4$$  ]1@=*9H5]X3NY)&T6T@5TABO&,6GM$=CA_+<?(,D@OC'/)
M]:=Q&9-\1)4L?ML>C;K;R9I][W!4[(S&,XV<\R@''3:V,\9OZ3XCN]6\51VQ
MA>VMEM9O,A<@DRK]F;/W01@3$=>>N!3%U?P8+2&[6RC\F^!2,KI4F9Q,ID/
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MU]%%)&QB6/"N)5)Y7)P<$<=R* .LU3XFZ?HFE0:EJ>CZO;VLEQ]G=_+B<0G
M(9MDARA!!#+NS]2 ;FL>/+'1K:^NY-/OKBRL[6&[:ZMC"R21RDA"F9 3RI[=
MO<54BLKZ_ATS3]2\.3?8(7:!UG:!OW/D; T@$A!RQ/"YP,5R$OP^U[1_"_B_
M0;!9-2MKR""'209$#)&'E=D8NRCY2Q_[Z!]0 #NM-\?6-_J%OITFGW]E?7=L
M+JS@NA$#=1X)RC*[+D 9()!'I4>A_$;1M=T+5-5ABN[9=,8K<V]RBK*"!D8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@J7QC;?8+K4([^X>^L)(4W><T@.8V[*0< DX!'/M0!T%[\2O#EC'HMQ-</\
M8=9(%I>J!Y6> 0YSE,9&<@8YST..CL]0%Y<W<*V\T8MG$9D?;M<E0WRX).,,
M.H%>>>&_A_#:^#=,\)ZW;O<+)8W/VJ1$^2*61XW #<C<N#ANF4[9 .]\.=#U
M?P[H]_INL7!N9(;UEM[@]9(!'&(R3W( QSTQCG% '8T444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]^0 1CF@#U,8ZXI<"@# HH ,48'I110 8HHHH ,48%%% !1110 8%&!Z444
M&!Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 86M^++#0=6TO
M3+J*Y>YU-S':B) P9AC()SQ]X'GC\C5;6_'.F^'[74+K4+>\2WL)(XYY5C#
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MNJWRG)<J.G-37-G=Z#\8%\13:7=R:;>:+]C#V-NT_ERB1#M8("0,#@XQ^1P
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M(V89 ;'!/XUYII]E<7-M\-?L\5T@L872\ECBW&W?[,T3!B5(W>9E3GODGUH
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M*\C;N SG!R,\<"M7P1;71O?M-]%K<6H):>1>K=HB6\DH89=-JCS"<$ALGY2
M?0 '0'Q9I?VEHE:>1%NULFFC@9HQ.6V^66 QD$@$] >,YXK7AN(KC?Y3J^QB
MC;3G##J/J*\XFTVZM]=;4/#UIJ%G=W&JA;_3IX&:SN4$N#<!B-J,5'F!E.2<
M#!/7/N=*O[>SO-.M](NU,M[J,@E2"1D 8MY((7&YF#';)G"$#.3B@#UA9XFG
M: .IE50[)GD Y )'H=I_(U)7DZV.N+;:G?06-\=4N]'T_P#>&$B60QEOM"Y.
M )"O 4\Y;..M=/H]I=Q^&-9;1?[4AN;D226:ZI&D?E3&/"[(]HV)N X(QG)
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MQ[V+*!DL>BYYZ\ANL^%YK2_M_P"QO"TD8A6QN(Y;-8QN9;C?*I\PCRR 2?E
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MV$X^<%3'&$_AV#H%% 'IAEC )+* .I)_"JT^I11-<11(]S<P1K(]O$5#[6)
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MAY@,1*[E#1LQ'7<%;H,U=_L))?A+J6DZ58SR74;O)]GN;<12>;O$N A)QA2
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MW4\L  >F0!5W<,XKQ^U\/:FT5TLWA^[-M'<Z7=10R11X*HRB8(NYOFP.<X)
MY)XSOZ7IFHOXQ>34-/U9+B&]DN(;Q'A6W-NPPJ,P^<X7"[,$94'/\5 'H)8
MXK)'B""37'TN&UNIFA98[B>-5,<#LA<*_P V[E=IR%(^9>>N.4\2:/J]_J>N
MQ+!,\UR+0Z1=HO%MM(WC<.5PP+'/W@V.<8K7\/:4;3Q=XIO6L?*%W=1-!,8M
MN]!#&KX..F]6^N,^] #E\=Z?LU"66QU**WTV9H;R<P!T@90&;.QB2 I!) (
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML)6(3K&CG8Q(60 $$=,46FB0R7.BS)::Y);C5Y+@C4(-IB0VTR_*B*/+CWE
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MK5E?ZEJ%A \AN+!D2X#1LH4LNX8)'/'<5?R#FO)+Q;XZWJ>IZ;:^($SJ6F&
MBWND\R$!!*64CY_EW [AQT^KR=>==76ZF\0)J]M%?>;':PR"&=&W^0T;C[W_
M "SVA,,"&S_%D ]+MM*L;34;O48(2MU=A!/)O8[]N=O!..,GI5W<*\IN[+4(
M1IML\_B.&ROM/CVS6ZSS31WF0'+;CF(XV8W?*,/TYS?@&NOK CE;4$U6/6P=
MVU_(?3\9P3_J\;,],XD^M '9P>(;&YU0V$(N)'#R1^<L#&+>F-ZEP, C..<<
M@@<@BM6O/O"MM#96%R;NVUB)I/$%P\*D7"$AIG,;$''R$'+$\'C=FO01TH *
M*** #K5/3])L-*686-LD/G2-+*5Y+L3DDD\G^G05<HH **** "BBB@!LD:31
M-'(BO&X*LK#((/4$5GZ=X?TK27+6-E'"<;1C)"#T4'[H]ACH/05I44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 9U_H6GZE=0W5Q%(+F%62.:&=X7"D@E=R$'!*CCIQ5
MRWMH+2!8+>)(HD^ZB# %2T4 %%%% !1110 4444 %175K!>VDUI<Q++;SHT<
ML;C(=2,$'V(-2T4 9^GZ+8:8X>VCDW!/+5I9GE*)Q\JER=HX' P.!Z5H444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDG)  !ZSUHR*YGP7J$^H:3<O<)B1+DQ[TNC<0R81,O$Y.2A.>#R#N!Z5Y_\
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MC<F2W8+*"I !(##DC!X(Z5YCX<&L6?A_PI]B6[>UU+2$L)(U9@+2?:I$^#P
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M2J2-Y+,>" 1]WD# X[UT%SJ^IR?!F'4WNIHM5;3HV:5!B0S8&>,?>)SP!^5
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MY9%$1MT8;G&3&I((# 9)4 8R2,73]<UB4:?JWVNYN-07PY<8WJ<&=9$W 1#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#Y?S F\KCKD+\Q]JX2ZU];AM-&E^-7FM=0U585F1(<HC0N60,5()# -T^4N
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MQQ^5 '94444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,J!QWYR>>M<A!-;W_P )?"-AIDR2^($>S>S2!@TL+*XWN1GY5$>_)/'.#UH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:(T5F8(H9OO$#D_6G44
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MG S^)_,TZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8[H"\2DQ'U7CY?PJS10!5?3;"24RO96S2%@Y9HE)W#H<XZ^]6!'&)&D"*)&
M4MCD@9P,_B?S-.HH KVEC:6$1BL[6"WC+%RD,80%CU.!W-4=5\.V&IZ??VZV
M\$$UY%)&]RD(\P;TV,V1@YV\9SV%:U% &=I>C6>EZ2FGQV]OY>W$H2$(LIP
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M[MG@&@#TS^T;$OL^V6^_.-OFKG/IUJS7FNCZ<]_XR\7)'9V,]J=5@%PTHQ(
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MJR+<2[)" #D1D89<_,N1N/:KM[XMUE;?47ME-S%9:E<02M:QHTT4*1J0^QB
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M+)<1R(K%E4*?F)<A<$#,9'?C?\4SW%KX3U>YM)S!<0V<LD<H7<594)!QWZ4
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M$7<P&6/0#W->6:+XEUE]%LK./5[-;VZ2_GCNKYPBL\=P5"?=;(4'+*,'!&"
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MK/XB\2W>C- -6DT.PGBW)E))/WQP1GH>G;''X]5H&OKK.FW&N+,PTL@&$2(
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M06ET]O'JEX$2*ZED >T16W&5"3\A'."O+-M!X&0 =HBQ01QPQJD: !$10
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M84KCYL$[@0*33O$?BF>*SNYKZTDANM1O-->"&SP\1C\XK)G>1QY7*D<@]SU
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MM?-^SV-M#YV?,\N%5WYZYP.?QIUEI]EIMO\ 9["TM[6'.?+@C"+GUP!BK-%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!-C_ . Z?X4 9_\ PG?@_P#Z&O0__!C#_P#%4?\ "=^#_P#H:]#_ /!C#_\
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MP_\ Q5:']@Z/_P! FQ_\!T_PH_L'1_\ H$V/_@.G^% &?_PG?@__ *&O0_\
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M"]AR>3@='10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
